Researchers have been developing diagnostic tools, potential vaccines, and drugs to fight viruses. Transmission of a recently identified SARS-CoV-2 coronavirus (previously 2019-nCoV) is very strong. GenScript now offers a complete portfolio of ready-to-use products for SARS-CoV-2 research. All proteins for COVID-19 research serve as excellent antigens in ELISA and Western Blot and in the rapid detection of relative virus seroconverters with optimal specificity.
To support COVID-19 research, we produce ready-to-use recombinant SARS-CoV-2 proteins that can be used as an antigen for analytical and immunodiagnostic purposes, as well as for vaccine development.
Our catalog of ready-to-use SARS-CoV-2 (COVID-19) proteins comprises SARS-COV-2 Spike S, SARS-CoV-2 Spike S1 RBD, Nucleocapsid (N) protein, Proteinase 3 CL-Mopar, M protein, an envelope protein (E), and other relevant proteins that are associated with coronavirus infection such as the hACE2 protein. In addition, we offer a wide range of important SARS-CoV-2 variants (spike mutant proteins). All proteins can be ordered from stock and have very short lead times.